SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Generation Income Properties disclosed its second quarter 2026 financial results via press release on August 17, 2026, reporting net loss attributable to common shareholders of $1.08 million for Q2 2026 (down 76% from $4.42 million in Q2 2025) and six-month net loss of $3.21 million, along with key operational metrics.
View raw filing on EDGAR →The disclosure centers on the appointment of David Sandberg to the Board of Directors effective immediately (Item 5.02(d)), with detailed background on his qualifications and investment holdings. While T. Allan McArtor's resignation is also disclosed (Item 5.02(b)), the substantive focus and length of the filing emphasizes the new director appointment. The appointment is material as it involves a change in board composition and a director with significant beneficial ownership stakes through Red Oak Partners' funds.
View raw filing on EDGAR →Pete Suerken, President U.S. of Wendy's, notified the Company on August 14, 2026 of his intention to resign effective August 31, 2026 to become President and CEO of QSCC. While the filing also discloses compensatory arrangements (pro-rated vesting acceleration and cash incentive payment), the principal disclosed action is Suerken's departure from a senior executive role. The filing also notes elimination of the President, U.S. position and creation of a new Chief Operations Officer role, underscoring the significance of this departure.
View raw filing on EDGAR →Illumina completed a public offering of $300 million in 4.950% notes due 2029, creating a new direct financial obligation. The company intends to use proceeds to repay existing 4.650% notes due September 2026. This is a material debt issuance disclosed under Item 8.01, representing a significant capital structure event that would affect investor assessment of the company's financial position and obligations.
View raw filing on EDGAR →Eric Foster, Chief Commercial Officer, notified the Company on August 11, 2026 of his resignation effective August 28, 2026. The disclosure centers on a named executive's departure from the Company. While disclosed under Item 8.01 (Other Events) rather than the typical Item 5.02, the substance is clearly an executive departure, and the CCO role is material to a commercial-stage biopharmaceutical company.
View raw filing on EDGAR →The filing discloses a derivative lawsuit filed on August 14, 2026, against GPHC and certain officers and directors, asserting claims for federal securities law violations, breach of fiduciary duty, aiding and abetting, waste of corporate assets, and unjust enrichment. This is material litigation that would affect a reasonable investor's assessment of the company's legal and financial exposure, particularly given the serious nature of the allegations and the involvement of current and former executives.
View raw filing on EDGAR →The announcement discloses a 1-for-40 reverse stock split undertaken specifically "to satisfy the minimum bid price requirement for maintaining listing on Nasdaq." This is a direct response to delisting risk — the company explicitly states the reverse split's purpose is to "increase the market price of the Company's common stock and allow it to satisfy the minimum bid price requirement for maintaining listing on Nasdaq," indicating the company was at risk of failing Nasdaq's continued listing standards.
View raw filing on EDGAR →AMD closed a public offering of $4.75 billion in senior notes across four tranches (2029, 2031, 2033, and 2036 maturities) on August 17, 2026, governed by an Indenture with U.S. Bank Trust Company. The offering includes detailed terms, interest rates, redemption provisions, and covenants.
View raw filing on EDGAR →Motorola Solutions closed an underwritten public offering of $950 million in aggregate principal amount of senior notes ($350 million 4.850% notes due 2029 and $600 million 5.650% notes due 2036). This is a material creation of direct financial obligations disclosed under Item 8.01, constituting a debt issuance event.
View raw filing on EDGAR →L. Paris Watts-Stanfield resigned from the Board of Directors of IDEX Corporation effective immediately on August 13, 2026. The disclosure centers on a director's departure, with the Board size reduced from ten to nine directors. While the resignation was not due to disagreement, the principal disclosed action is a person leaving a governance role, which is material to investors' assessment of board composition and leadership continuity.
View raw filing on EDGAR →The disclosure centers on Nir Naor's appointment as principal financial and accounting officer on August 12, 2026, and his concurrent appointment as Corporate Secretary, with his title modified to Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer. While the section also mentions Francis X. Brown III's interim role ending, the principal action disclosed is Naor's appointment to key financial and governance roles. The appointment of a CFO and principal financial officer is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Aardvark Therapeutics' 2026 Annual Meeting of Stockholders held on August 14, 2026. The filing presents voting outcomes for three proposals: election of two Class I directors (Victor Tong, Jr. and Jeffrey Chi, Ph.D.), ratification of BDO USA, P.C. as independent auditor, and approval of stock option repricing under three equity plans. All three proposals passed. This is material as shareholder votes on director elections, auditor ratification, and equity compensation arrangements directly affect investor assessment of governance and capital structure.
View raw filing on EDGAR →The filing discloses an ongoing merger transaction between Essential Utilities and American Water, with American Water's subsidiary (Merger Sub) merging into Essential Utilities. Although the merger has not yet closed and is subject to regulatory approvals, the Item 7.01 disclosure furnishes American Water's interim financial statements in connection with this material acquisition. The merger was previously disclosed in an October 2025 8-K and remains a pending material transaction subject to customary closing conditions.
View raw filing on EDGAR →The company entered into material definitive agreements in connection with a merger transaction, including assumption of substantial debt obligations ($5.85 billion in unsecured notes across three indentures) and credit facilities ($2.5 billion revolving + $550 million term loan). The disclosure documents the debt and credit facility restructuring that accompanies the merger, which constitutes a material acquisition or change of control event.
View raw filing on EDGAR →On August 17, 2026, UHS completed its acquisition of Talkspace for $5.25 per share in cash, creating a full continuum of behavioral healthcare services. The transaction was financed through borrowings under a delayed draw term loan facility ($400 million) and additional funds under a revolving credit facility.
View raw filing on EDGAR →The 6-K discloses the closing of a secondary offering by a selling shareholder of 28.1 million ordinary shares, with 15.4 million shares sold publicly at $39.35 per share and 12.8 million shares repurchased by the Company via redemption. While the offering itself is by the selling shareholder (not a primary issuance by the Company), the Company's concurrent share redemption and cancellation of 12.8 million shares represents a capital transaction material to investors. The net effect involves significant share activity and capital deployment (~$500 million redemption amount), though the public offering by the selling shareholder does not directly dilute existing shareholders in the traditional sense.
View raw filing on EDGAR →The disclosure centers on Nadin Virani's appointment as interim Chief Financial Officer effective August 17, 2026, a material executive role. While Edmund Reese's transition from CFO is also disclosed, the principal action emphasized is Virani's appointment to fill the CFO position, supported by details of his background, compensation adjustment ($50,000/month increase), and bonus eligibility. This is a material change in senior leadership affecting investor assessment of the company's financial management.
View raw filing on EDGAR →The filing discloses the completion of a material acquisition of CNL Healthcare Properties, Inc. (CHP) by Sonida Senior Living on March 11, 2026, pursuant to a definitive merger agreement dated November 4, 2025. The Item 8.01 filing provides pro forma financial statements reflecting the acquisition as if it had occurred on January 1, 2025, and details the substantial financing transactions ($110 million equity, $1.0 billion debt) and transaction costs incurred to complete the CHP Merger. This is a completed material acquisition that would materially affect investor assessment of the registrant.
View raw filing on EDGAR →Phoenix Energy One entered into Amendment No. 10 to its Senior Secured Credit Agreement on August 12, 2026, establishing and immediately drawing $75 million in Amendment No. 7 Discretionary Delayed Draw Term Loan Commitments with a 3.00% original issue discount. The proceeds are designated for oil and gas property development.
View raw filing on EDGAR →AT&T closed the sale of €1.2 billion in Floating Rate Global Notes due 2028 and $1.1 billion in Floating Rate Global Notes due 2028, creating new direct financial obligations totaling approximately $2.3 billion in aggregate principal amount. This is a material debt issuance under Item 2.03 (or disclosed under Item 8.01 as here), representing the creation of new debt securities registered under the Securities Act of 1933.
View raw filing on EDGAR →Maze Therapeutics appointed two new directors to its Board: Paula A. Johnson, M.D., M.P.H. as a Class III director and Sophie Kornowski, Pharm.D. as a Class I director, both effective August 13, 2026. Both appointees bring substantial clinical and biopharmaceutical leadership experience, including prior roles at major pharmaceutical companies and academic institutions.
View raw filing on EDGAR →Fred Stephan was appointed Chief Executive Officer and President effective November 1, 2026, following a deliberate Board succession process. The appointment includes his election as a Class III director and a comprehensive compensation package ($1.15M base salary, $1.44M short-term incentive target, $4.43M long-term incentive target, plus $3.77M and $2M RSU grants). Keith Harvey transitioned from CEO to Executive Chairman as part of this leadership succession.
View raw filing on EDGAR →The Mosaic Company closed the sale of $2.0 billion in aggregate principal amount of senior notes across three tranches (5.350% due 2031, 5.650% due 2034, and 5.900% due 2036) on August 17, 2026. Net proceeds of approximately $1.98 billion will be used to fund tender offers for existing debt and general corporate purposes.
View raw filing on EDGAR →CVS Health appointed Teresa Heitsenrether to its board of directors effective November 18, 2026. Heitsenrether is a senior executive from JPMorgan Chase with nearly forty years of financial services leadership experience, bringing expertise in data, analytics, and technology transformation to the company's board during a strategic transition period.
View raw filing on EDGAR →MasTec completed a public offering of $650.0 million aggregate principal amount of 5.850% senior unsecured notes due 2036 on August 17, 2026. This represents a material creation of a direct financial obligation with a 10-year maturity, disclosed across Items 1.01 and 2.03.
View raw filing on EDGAR →The filing discloses the sale of Vantage at Loveland, a material equity investment, with redemption of the Partnership's $23.2 million contributed equity and return of $2.5 million in accrued preferred return, generating approximately $0.11 per BUC in net income and cash available for distribution. While this is a disposition of an investment asset, it is not a traditional M&A activity (acquisition, merger, or change of control) but rather a capital redeployment event that affects the Partnership's financial position and distributable cash. The event is material to investors as it impacts quarterly earnings and distributions, but does not fit neatly into the M&A taxonomy.
View raw filing on EDGAR →NNN REIT appointed Christina Chiu and Charles D. Mueller, Jr. to the Board of Directors effective October 1, 2026, as part of staged succession planning. Both appointees bring substantial REIT and executive leadership experience and will serve on the Audit Committee.
View raw filing on EDGAR →KPMG LLP was dismissed as the Company's principal accountant effective August 13, 2026, and PricewaterhouseCoopers LLP was appointed as the new independent registered public accounting firm for the fiscal year ending June 30, 2027. No disagreements or reportable events with KPMG were disclosed.
View raw filing on EDGAR →Ronald Taylor, a director and Lead Director of Resmed for over 21 years, announced his retirement from the Board effective at the November 2026 Annual Meeting, and Carol Burt was appointed as his successor in the Lead Director role effective November 15, 2026. This represents a board-level governance transition in the Lead Director position.
View raw filing on EDGAR →Flexsteel Industries issued a press release on August 17, 2026 announcing fourth quarter and fiscal year 2026 operating results, including net sales of $459.2 million (4.1% growth), GAAP net income of $33.1 million, and record adjusted diluted EPS of $4.94, along with forward guidance for Q1 FY2027.
View raw filing on EDGAR →The filing discloses a change in the registrant's independent accountant under Item 4.01: dismissal of Deloitte & Touche LLP effective August 14, 2026, and engagement of KPMG LLP as the new independent registered public accounting firm. The disclosure explicitly states there were no disagreements, adverse opinions, or reportable events, indicating a routine auditor transition. This is a textbook auditor_change event.
View raw filing on EDGAR →Black Hills Corporation is disclosing the pending merger with NorthWestern Energy Group, Inc., an all-stock business combination entered into on August 18, 2025. The filing provides historical financial statements of NorthWestern and pro forma combined financial information as required by Regulation S-X. Multiple regulatory approvals have been obtained (FERC, NPSC, SDPUC), with the transaction awaiting final Montana PSC approval. This is a material acquisition/merger activity that would substantially affect the combined entity's financial position and operations.
View raw filing on EDGAR →Palmer Square Capital BDC Inc. discloses management's unaudited estimate of net asset value (NAV) per share as of July 31, 2026 ($13.39). For a Business Development Company (BDC), NAV is a critical metric for investor valuation and pricing. While this is a routine monthly or periodic disclosure common to BDCs, it is material to investors assessing the fund's performance and share value. The disclosure does not fit neatly into specific event categories (not earnings, not a restatement, not a material impairment), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses the appointment of Andra Frazier as Executive Vice President and Chief Credit Officer of CalPrivate Bank, announced via press release on August 17, 2026. This is a named executive appointment to a material C-suite position responsible for credit risk management at a $2.71 billion asset bank. The appointment of a Chief Credit Officer is material to investors assessing the registrant's risk management and governance structure.
View raw filing on EDGAR →DynaResource announced a non-brokered private placement of units at $0.45 per unit to raise $3.0 million (up to $6.4 million with warrant exercise) to existing stockholders. The offering comprises common shares and warrants, representing a dilutive equity issuance. The company has received an advance commitment of $851,250, though completion remains subject to definitive documentation. This is a material capital-raising event typical of small-cap issuers under Item 3.02 (Unregistered Sales of Equity Securities), disclosed here under Item 8.01.
View raw filing on EDGAR →Dr. Raj Talluri resigned as President, Chief Executive Officer, and director of Enovix Corp effective August 13, 2026, to pursue another opportunity. The filing discloses a leadership transition with the appointment of Ryan Benton as interim CEO and T.J. Rodgers as executive chairman.
View raw filing on EDGAR →The exhibit announces a cash dividend declaration of $0.17 per share (approximately $9.8 million total) payable on September 17, 2026, to shareholders of record as of August 27, 2026. This is a straightforward dividend distribution event. While the announcement also references "record-high revenue and profitability for first six months of 2026," the primary disclosed action is the dividend declaration itself, which is material to shareholders as a return of capital and signal of the company's financial confidence and liquidity position.
View raw filing on EDGAR →This is a press release announcing BitFuFu's unaudited second quarter 2026 financial results, including revenue ($42.8M, down 62.9% YoY), net loss ($20.5M vs. net income of $47.1M in Q2 2025), and adjusted EBITDA (negative $18.4M). The document contains condensed consolidated financial statements and is clearly a discrete earnings announcement, not a periodic financial report filing. The substantial revenue decline and shift from profitability to loss are material to investors.
View raw filing on EDGAR →This press release announces Mobilicom's strategic positioning to capitalize on new U.S. federal tariff policy on foreign drones and UAS components signed August 13, 2026. The disclosure highlights the company's alignment with regulatory initiatives (FCC Trusted Drone status, NDAA compliance, U.S. onshore manufacturing buildout) in response to a material shift in the competitive and regulatory landscape. While not a discrete transaction or M&A event, this represents a significant operational and strategic development affecting the company's market opportunity and positioning in the U.S. defense and commercial drone sectors.
View raw filing on EDGAR →This press release announces new preclinical findings demonstrating that namodenoson enhances the anti-cancer effect of gemcitabine in pancreatic cancer, providing mechanistic support for Can-Fite's planned Phase IIb study. While the disclosure concerns drug development progress and clinical trial advancement—core operational matters for a clinical-stage biotech—it does not fit the specific event types of earnings_release (no financial results), material_litigation, or other named categories. The announcement of positive preclinical data supporting an upcoming Phase IIb trial represents a material operational/strategic milestone that would affect a reasonable investor's assessment of the company's pipeline progress and development strategy.
View raw filing on EDGAR →The filing discloses quarterly financial results for Q2 2026 (ended June 30, 2026) via a press release attached as Exhibit 99.1. The Item 2.02 section explicitly states the Company "issued a press release that included financial information for its quarter ended June 30, 2026," and the press release reports key metrics including cash position ($28.7M), R&D expenses ($440K), G&A expenses ($5.4M), net loss ($52.0M), and loss per share ($(11.25)). While the filing also discloses concurrent M&A activity (Azora acquisition) and financing, the Item 2.02 classification and the press release structure center on the quarterly earnings disclosure.
View raw filing on EDGAR →The press release announces authorization of a US$2,000,000 share repurchase program by the board of directors, effective until December 31, 2027. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The program is material as it represents a significant commitment of capital and signals management's confidence in the company's valuation.
View raw filing on EDGAR →This announcement discloses a scheduled End-of-Phase 2 meeting with the U.S. FDA for RAD 101, a pivotal clinical development milestone. The company reports positive Phase 2b trial results (93% concordance with MRI) and confirms it remains on track to be Phase 3-ready by year-end 2026. This is a material operational/regulatory milestone for a clinical-stage biopharmaceutical company advancing a lead candidate toward pivotal trials, but it does not fit the specific event types (e.g., it is not an earnings release, executive change, M&A activity, or material impairment). The disclosure would affect a reasonable investor's assessment of the company's clinical development progress and regulatory pathway.
View raw filing on EDGAR →WhiteFiber entered into a definitive Real Estate Purchase and Sale Agreement on August 16, 2026, to acquire two industrial properties in Yadkin County, North Carolina for $60.0 million cash through its subsidiary Enovum Data Centers Corp. The properties will be converted into data center campuses (NC-2 and NC-3) with initial operational capacity of 60 MW and potential expansion to up to 198 MW, representing a material expansion of the company's data center footprint and AI infrastructure platform.
View raw filing on EDGAR →Rajesh Goel notified REE Automotive of his resignation from the Company's Board of Directors effective immediately on August 13, 2026. This is a clear executive departure — a director leaving the board. Board departures are material to investors as they affect governance and oversight structure, and the filing explicitly discloses this as the principal content of the 6-K.
View raw filing on EDGAR →Steven Przybyla was appointed as President of Ispire Technology Inc., effective August 11, 2026, in addition to his existing roles as Chief Legal Officer and Secretary. The appointment strengthens the company's U.S.-based leadership and investor communications capabilities.
View raw filing on EDGAR →The 6-K discloses the appointment of Ms. Shanyu Chang as Chief Financial Officer effective August 17, 2026, following the resignation of Mr. Huaguang Huang. While both a departure and appointment occur, the principal disclosed action is the appointment of a named executive to a C-suite role (CFO), which is the forward-looking governance event. The filing includes biographical information establishing Ms. Chang's qualifications and confirming no conflicts of interest, consistent with exec_appointment disclosure practice.
View raw filing on EDGAR →Serve Robotics announced multiple operational and strategic business developments including a partnership with Grubhub/Wonder for robot delivery expansion, entry into two new major markets (Washington DC and San Jose), launch of a micro-depot model in Miami, rollout of next-generation Moxi 2.0 hospital robots with enhanced capabilities, and introduction of new products (Beacon countertop device and Characters advertising service).
View raw filing on EDGAR →NewGenIVF completed an exchange of existing convertible notes for a new senior convertible note with amended terms, closing August 14, 2026. While technically a restructuring of existing debt rather than issuance of entirely new debt, the creation of a "new senior convertible note" with materially modified terms (elimination of mandatory proceeds sweep, leak-out framework) constitutes a material modification of the Company's direct financial obligations. This restructuring materially affects the capital structure and future financing flexibility, making it material to investors assessing the registrant's financial position and obligations.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release attached as Exhibit 99.1 under Item 2.02. The filing presents comprehensive financial results including revenue ($1.87M, up 2%), gross profit, operating loss, and net loss ($2.6M), along with balance sheet and cash flow statements. The disclosure is material as it reveals significant operational challenges including widening losses, going-concern doubts, Nasdaq delisting, and termination of the BullionFX acquisition letter of intent.
View raw filing on EDGAR →